Literature DB >> 25393763

In vitro evolution and affinity-maturation with Coliphage qβ display.

Claudia Skamel1, Stephen G Aller2, Alain Bopda Waffo3.   

Abstract

The Escherichia coli bacteriophage, Qβ (Coliphage Qβ), offers a favorable alternative to M13 for in vitro evolution of displayed peptides and proteins due to high mutagenesis rates in Qβ RNA replication that better simulate the affinity maturation processes of the immune response. We describe a benchtop in vitro evolution system using Qβ display of the VP1 G-H loop peptide of foot-and-mouth disease virus (FMDV). DNA encoding the G-H loop was fused to the A1 minor coat protein of Qβ resulting in a replication-competent hybrid phage that efficiently displayed the FMDV peptide. The surface-localized FMDV VP1 G-H loop cross-reacted with the anti-FMDV monoclonal antibody (mAb) SD6 and was found to decorate the corners of the Qβ icosahedral shell by electron microscopy. Evolution of Qβ-displayed peptides, starting from fully degenerate coding sequences corresponding to the immunodominant region of VP1, allowed rapid in vitro affinity maturation to SD6 mAb. Qβ selected under evolutionary pressure revealed a non-canonical, but essential epitope for mAb SD6 recognition consisting of an Arg-Gly tandem pair. Finally, the selected hybrid phages induced polyclonal antibodies in guinea pigs with good affinity to both FMDV and hybrid Qβ-G-H loop, validating the requirement of the tandem pair epitope. Qβ-display emerges as a novel framework for rapid in vitro evolution with affinity-maturation to molecular targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25393763      PMCID: PMC4231119          DOI: 10.1371/journal.pone.0113069

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  41 in total

Review 1.  Foot-and-mouth disease and beyond: vaccine design, past, present and future.

Authors:  F Brown
Journal:  Arch Virol Suppl       Date:  1999

Review 2.  Phage display technology: clinical applications and recent innovations.

Authors:  Hassan M E Azzazy; W Edward Highsmith
Journal:  Clin Biochem       Date:  2002-09       Impact factor: 3.281

3.  Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components.

Authors:  F BROWN; B CARTWRIGHT
Journal:  Nature       Date:  1961-12-23       Impact factor: 49.962

4.  Libraries of peptides and proteins displayed on filamentous phage.

Authors:  G P Smith; J K Scott
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

Review 5.  RNA phage Q beta coat protein as a carrier for foreign epitopes.

Authors:  T M Kozlovska; I Cielens; I Vasiljeva; A Strelnikova; A Kazaks; A Dislers; D Dreilina; V Ose; I Gusars; P Pumpens
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

6.  Transformation of Burkholderia pseudomallei by electroporation.

Authors:  K Mack; R W Titball
Journal:  Anal Biochem       Date:  1996-11-01       Impact factor: 3.365

7.  The readthrough protein A1 is essential for the formation of viable Q beta particles.

Authors:  H Hofstetter; H J Monstein; C Weissmann
Journal:  Biochim Biophys Acta       Date:  1974-12-06

8.  The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle.

Authors:  M Eigen; P Schuster
Journal:  Naturwissenschaften       Date:  1977-11

9.  Bacteriophage distribution in human faeces: continuous survey of healthy subjects and patients with internal and leukaemic diseases.

Authors:  K Furuse; S Osawa; J Kawashiro; R Tanaka; A Ozawa; S Sawamura; Y Yanagawa; T Nagao; I Watanabe
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

10.  Structure of a major immunogenic site on foot-and-mouth disease virus.

Authors:  D Logan; R Abu-Ghazaleh; W Blakemore; S Curry; T Jackson; A King; S Lea; R Lewis; J Newman; N Parry
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

View more
  6 in total

1.  Engineering the PP7 Virus Capsid as a Peptide Display Platform.

Authors:  Liangjun Zhao; Mykhailo Kopylov; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  ACS Nano       Date:  2019-03-26       Impact factor: 15.881

Review 2.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

3.  Correction: In Vitro Evolution and Affinity-Maturation with Coliphage Qβ Display.

Authors:  Claudia Skamel; Stephen G Aller; Alain Bopda Waffo
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

Review 4.  RNA Phage VLP-Based Vaccine Platforms.

Authors:  David S Peabody; Julianne Peabody; Steven B Bradfute; Bryce Chackerian
Journal:  Pharmaceuticals (Basel)       Date:  2021-08-04

Review 5.  Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals.

Authors:  Donghyeok Gang; Do Wook Kim; Hee-Sung Park
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

Review 6.  Uniqueness of RNA Coliphage Qβ Display System in Directed Evolutionary Biotechnology.

Authors:  Godwin W Nchinda; Nadia Al-Atoom; Mamie T Coats; Jacqueline M Cameron; Alain B Waffo
Journal:  Viruses       Date:  2021-03-27       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.